Status: Recruiting
Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group. Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years
Participants needed: 8,000
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Spanish Breast Cancer Research GroupUpdated: May 14, 2025Locations: 73
Eligibility criteria
Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's part... [+1]
Patient who were not included in the analyses of the original studies due to non...